Flora Binder to join Dillico as Chief Development Officer

We are pleased to announce today that Flora Binder has taken up her role of Dillico’s Chief Development Officer. “Flora has a solid expertise in mRNA process transfer in the global pharmaceutical industry and it will be a significant asset to Dillico to advance our vision to modernize mRNA-LNP manufacturing. On behalf of our team, I want to warmly welcome Flora as a new member of the management,” said Christophe Bonneville, [...]

1 March 2023|

French Tech Emergence Grant for Dillico

Dillico is pleased to announce that it has been awarded a French Tech Emergence grant by BPIFrance, which we thank. This financial support is granted to startup projects that develop a disruptive innovation with high technological content. It allows to conduct feasibility studies still needed. Dillico will use this [...]

30 January 2023|